Lates News

Aimovig and Amjevita will be offered at a discounted price of $299 per month. The "Direct-to-Patient" program AmgenNow will be expanded to include Aimovig (erenumab-aooe) and Amjevita (adalimumab-atto). All three drugs will also be available through TRUMPRX.GOV. Working with the U.S. government to take action to lower drug costs for American patients. Amgen has invested over $40 billion in manufacturing and research and development since 2018.